Oncology

  • The Mainstreaming of Targeted Lung Cancer Treatment

    The Mainstreaming of Targeted Lung Cancer Treatment

    Our CMO speaks with Managed Care Executive about the promise and perils of genomic testing.

    Read External Article
  • Health Systems' Rare Rejection of Alzheimer's Drug Sparks Questions About FDA Approvals

    Health Systems' Rare Rejection of Alzheimer's Drug Sparks Questions About FDA Approvals

    Modern Healthcare spoke with NCH's Dr. Andrew Hertler about problems in the FDA's approval process.

    Watch Video
  • ×

    First Name
    Last Name
    Company Name
    Thank you!
    Error - something went wrong!
  • Specialty Pharmacies Grapple with Assessing Costs and Value of Oncology Therapies

    Specialty Pharmacies Grapple with Assessing Costs and Value of Oncology Therapies

    Our CMO speaks with Formulary Watch about the challenges of high--cost drugs with marginal benefit.

    Watch Video
  • Hitting the Brakes on Fast-Tracked Drugs

    Hitting the Brakes on Fast-Tracked Drugs

    The FDA's Aduhelm approval was highly controversial, but not as surprising for those who follow the oncology drug pipeline.

    Watch Video
  • Let's Go
  • New Century Health Supports Neighborhood Health Plan of Rhode Island with Comprehensive Oncology Management Services

    New Century Health Supports Neighborhood Health Plan of Rhode Island with Comprehensive Oncology Management Services

    New Century Health, a national leader in specialty care management, is proud to provide comprehensive oncology specialty management services to Neighborhood Health Plan of Rhode Island.

    Watch Video
  • CMO Dr. Andrew Hertler Reacts to the FDA's Recent ODAC Meeting

    CMO Dr. Andrew Hertler Reacts to the FDA's Recent ODAC Meeting

    New Century Health CMO, Dr. Andrew Hertler, shares his thoughts on the recent FDA meetings to review the merits of approved cancer drugs.

    Watch Video
  • A now-or-never moment for telehealth?

    A now-or-never moment for telehealth?

    Our CMO Dr. Andrew Hertler speaks with HFMA about the role of telehealth in oncology care today.

    Read External Article
  • Episode 4: Keeping Up in the New Era of Cancer Care

    Episode 4: Keeping Up in the New Era of Cancer Care

    From cytotoxic chemotherapy to targeted therapy: we’ve entered a new era of cancer care. What is life like as a provider in this new era? How can oncologists keep up with the latest science?

    Watch Video
  • Episode 3: Debunking the Myths Surrounding Palliative Care

    Episode 3: Debunking the Myths Surrounding Palliative Care

    Palliative care—supportive care—is a glaring need in cancer care, but myths, misconceptions and mixed messages create barriers for broader palliative program implementation.

    Watch Video
  • Episode 1: Getting Precise About the Promise of Precision Medicine

    Episode 1: Getting Precise About the Promise of Precision Medicine

    There is tremendous excitement around the concept of precision oncology. But how many patients will truly benefit from these treatments? And do the results for these patients justify the hype?

    Watch Video
  • Introduction to Leading Causes: A Podcast by New Century Health

    Introduction to Leading Causes: A Podcast by New Century Health

    In this podcast series we explore the trends and forces behind the two leading causes of death in the United States: cancer and heart disease.

    Listen to Podcast
  • New Century Health Reports Year of Record Growth and Clinical Innovation in 2020

    New Century Health Reports Year of Record Growth and Clinical Innovation in 2020

    New Century Health announced that 2020 was the largest membership growth year in the 19-year history of the company.

    Watch Video
  • A Redesigned Prior Authorization is Needed in Oncology. Here's How.

    A Redesigned Prior Authorization is Needed in Oncology. Here's How.

    Payer strains now top the list of stressors facing oncologists, with prior authorization as the most-cited source of that payer stress.

    Watch Video
  • Pathways, Portals and Persuasion: Reining in an Overused Cancer Agent

    Pathways, Portals and Persuasion: Reining in an Overused Cancer Agent

    NCH's approach to more appropriate use of myeloid growth factor provides a playbook for how to change prescribing patterns.

    Watch Video
  • Learn More
  • Experts and Execs Weigh In: Oncology Care in 2021 and Beyond

    Experts and Execs Weigh In: Oncology Care in 2021 and Beyond

    New Century Health recently convened health plan executives, industry experts and oncologists from across the nation to discuss the confluence of forces shaping oncology care in 2021 and beyond.

    Watch Video
  • New Century Health to Support Florida Blue Medicare with Comprehensive Oncology Management Services

    New Century Health to Support Florida Blue Medicare with Comprehensive Oncology Management Services

    The company will leverage New Century Health’s oncology specialty management program to help ensure its more than 125,000 Medicare Advantage members receive high-quality cancer care.

    Watch Video
  • Oncology Quickly Adapted for the Pandemic. Here are 5 Changes Worth Keeping

    Oncology Quickly Adapted for the Pandemic. Here are 5 Changes Worth Keeping

    Read External Article
  • Video: Cancer Care Costs Everyone Too Much. What Can Health Plans Do About It?

    Video: Cancer Care Costs Everyone Too Much. What Can Health Plans Do About It?

    New Century Health’s John Davis hosts a virtual “fireside chat” with Dr. Elizabeth Malko, Dr. Vinay Prasad, and Dr. Andrew Hertler.

    Watch Video
  • Key Forces Impacting Cancer Care: An Interview with Dr. Vinay Prasad

    Key Forces Impacting Cancer Care: An Interview with Dr. Vinay Prasad

    New Century Health's John Davis recently sat down with Dr. Prasad, author of "Malignant: How Bad Policy and Bad Evidence Harm People with Cancer," to discuss key forces impacting cancer care.

    Watch Video
  • How Real-World Evidence Can Transform High-Value Oncology Pathways

    How Real-World Evidence Can Transform High-Value Oncology Pathways

    Our CMO Dr. Andrew Hertler explains how real world evidence may usher in the next generation of clinical oncology pathways.

    Watch Video
  • loading
    Loading More...